This work reports a facile strategy for preparing a highly efficient capsule bifunctional catalyst by direct coating copper–zinc–aluminum oxalate with H-ZSM-5, showing outstanding catalytic properties for dimethyl ether production from syngas.
Dimethyl ether (DME) is an industrially important intermediate and clean alternative fuel. Thus, developing an efficient bifunctional catalyst for syngas‐to‐DME is practically important but remains a challenge. In this paper, a copper−zinc implanting into matrix of mesoporous alumina (CuZn@m−Al2O3) catalyst was prepared by introducing the as‐prepared Cu−Zn oxalate nanoparticles into the Al(i‐OPr)3‐containing precursor solution for preparing mesoporous Al2O3 (m‐Al2O3) through evaporation‐inducing assembly method. The preparation of Cu−Zn oxalate in advance for synthesizing CuZn@m−Al2O3 can intensify the Cu−ZnO interaction, confirmed by XRD and H2‐TPR. Thanks to the unique CuZn‐implanting closed structure, CuZn@m−Al2O3 shows 89.0 % of higher selectivity with comparable CO conversion (15.5 %) than the previously reported supported‐type CuZn catalyst on m‐Al2O3 (CuZn/m−Al2O3, 75.2 %) for hydrogenation of syngas to DME. Over the developed CuZn@m−Al2O3 catalyst, 0.16 mmol g−1 cat h−1 of high DME rate can be achieved. CuZn@m−Al2O3 also shows higher methanation resistance (2.7 % CH4) compared to CuZn/m−Al2O3 (6.3 %), ascribed to intensified Cu−Zn interaction owing to the as‐formation of Cu−Zn oxalate in advance. Moreover, Both CuZn@m−Al2O3 and CuZn/m−Al2O3 exhibit high stability. The outstanding catalytic performance of CuZn@m−Al2O3 allows it to be a promising catalyst for DME synthesis from syngas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.